Author: Rodney A. Appell
Publisher: Adis International
ISSN: 1170-229X
Source: Drugs & Aging, Vol.21, Iss.13, 2004-01, pp. : 893-894
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Extended-Release Oxybutynin: A Viewpoint by Rodney U. Anderson
By Leach G.E.
Drugs & Aging, Vol. 16, Iss. 2, 2000-02 ,pp. :
The Clinical Pharmacokinetics of Darifenacin
Clinical Pharmacokinetics, Vol. 45, Iss. 4, 2006-01 ,pp. :
Darifenacin: In the Treatment of Overactive Bladder
By Katherine F. Croom Gillian M. Keating
Drugs & Aging, Vol. 21, Iss. 13, 2004-01 ,pp. :
Darifenacin improves symptoms in overactive bladder
Inpharma, Vol. 1, Iss. 1449, 2004-01 ,pp. :
Darifenacin improves HRQOL in patients with OAB
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 517, 2006-01 ,pp. :